Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • stockmasterp stockmasterp Jan 28, 2013 2:53 PM Flag

    The firm more than doubled its price target on the stock, to $15 from $7, and projected Zerenex will be approved for sale in U.S. and European markets by next year. Keryx shares surged 94% Monday to $6.65, and the company's market value rose to $478 million.

    The firm more than doubled its price target on the stock, to $15 from $7, and projected Zerenex will be approved for sale in U.S. and European markets by next year. Keryx shares surged 94% Monday to $6.65, and the company's market value rose to $478 million.

    Sentiment: Strong Buy

 
KERX
3.425+0.185(+5.71%)Feb 12 3:59 PMEST